Beck Bode LLC’s NuVasive, Inc. NUVA Stock Holding History

Beck Bode LLC’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-19,764	Closed	-$1.1M	–	324
2020 Q2	$1.1M	Buy	19,764 +3,482	+21%	+$201K	0.45%	32
2020 Q1	$991K	Buy	+16,282	New	+$1.09M	0.46%	34

Other funds holding NUVA

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Beck Bode LLC's NUVA Position: Q3 2020 in Review

Beck Bode LLC sold out of NuVasive, Inc. (NUVA) in Q3 2020, closing a stake of 19,764 shares — an estimated $1.1M sold.

Beck Bode LLC first reported a position in NUVA in Q1 2020 and held it in 2 quarters. The position peaked at $1.1M in Q2 2020. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2020.

Beck Bode LLC reported no remaining NuVasive, Inc. position as of Q3 2020 after selling out during the quarter.
Beck Bode LLC sold 19,764 NuVasive, Inc. shares in Q3 2020, an estimated $1.1M.
Beck Bode LLC first reported a position in NuVasive, Inc. in Q1 2020 and held it in 2 quarters.
Beck Bode LLC's NuVasive, Inc. position peaked at $1.1M in Q2 2020.
263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2020.

Based on Beck Bode LLC's 13F filing for Q3 2020, filed 12 Nov 2020.